Archives of Endocrinology and Metabolism (Jun 2020)

Reference values of 25-hydroxyvitamin D revisited: a position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society of Clinical Pathology/Laboratory Medicine (SBPC)

  • Carolina Aguiar Moreira,
  • Carlos Eduardo dos S Ferreira,
  • Miguel Madeira,
  • Barbara Campolina Carvalho Silva,
  • Sergio Setsuo Maeda,
  • Marcelo Cidade Batista,
  • Francisco Bandeira,
  • Victória Z. Cochenski Borba,
  • Marise Lazaretti-Castro

DOI
https://doi.org/10.20945/2359-3997000000258
Journal volume & issue
Vol. 64, no. 4
pp. 462 – 478

Abstract

Read online

ABSTRACT Hypovitaminosis D is a common condition with a negative impact on health. This statement, prepared by experts from the Brazilian Society of Endocrinology and Metabolism and the Brazilian Society of Clinical Pathology/Laboratory Medicine, includes methodological aspects and limitations of the measurement of 25-hydroxyvitamin D [25(OH)D] for identification of vitamin D status, and identifies individuals at increased risk for deficiency of this vitamin in whom 25(OH)D measurement is recommended. For the general population, 25(OH)D levels between 20 and 60 ng/mL are considered normal, while individuals with levels below 20 ng/mL are considered to be vitamin D deficient. This statement identifies potential benefits of maintaining 25(OH)D levels > 30 ng/mL in specific conditions, including patients aged > 65 years or pregnant, those with recurrent falls, fragility fractures, osteoporosis, secondary hyperparathyroidism, chronic kidney disease, or cancer, and individuals using drugs with the potential to affect the vitamin D metabolism. This statement also calls attention to the risk of vitamin D intoxication, a life-threatening condition that occurs at 25(OH)D levels above 100 ng/mL

Keywords